Oxford BioDynamics offers a novel and revolutionary diagnostic technology for the fast, reliable, sensitive and specific detection of aberrant gene expression. By combining a unique molecular biology assay with proprietary mathematical analysis of the specific DNA sequences within the locus of a gene, Oxford BioDynamics has been able to test and detect unambiguously specific high-order chromosomal epigenetic
conformations unique to specific genes and their expression states, including the abnormal ones.The technology offers highly affordable means of screening; early detection; monitoring and prognosis of major diseases associated with aberrant gene expression, i.e. cancer, inflammatory, cardiovascular, and neurodegenerative conditions, such as Alzheimer’s disease. The technology provides an early detection of aberrant gene expression
in a very low copy number of abnormal cells, literally finding a needle in a hay stack at the early stage of the disease. Oxford BioDynamics is setting up regional diagnostic health-care service providers in South-East Asia and the Middle East, to commercialize the technology in different diagnostic and therapeutic areas.